Generic Yasmin Availability – Drugs.com

Print

Save

Last updated on Jun 7, 2023.

Yasmin is a brand name of drospirenone/ethinyl estradiol, approved by the FDA in the following formulation(s):

YASMIN (drospirenone; ethinyl estradiol – tablet;oral-28)

• Manufacturer: BAYER HLTHCARE
  Approval date: May 11, 2001
  Strength(s): 3MG;0.03MG ^[RLD][AB]

Has a generic version of Yasmin been approved?

Yes. The following products are equivalent to Yasmin:

DROSPIRENONE AND ETHINYL ESTRADIOL (drospirenone; ethinyl estradiol tablet;oral-28)

• Manufacturer: BARR
  Approval date: May 9, 2008
  Strength(s): 3MG;0.03MG ^[AB]
• Manufacturer: DR REDDYS LABS SA
  Approval date: September 7, 2010
  Strength(s): 3MG;0.03MG ^[AB]
• Manufacturer: GLENMARK PHARMS LTD
  Approval date: March 25, 2016
  Strength(s): 3MG;0.03MG ^[AB]
• Manufacturer: HETERO LABS
  Approval date: January 24, 2020
  Strength(s): 3MG;0. 03MG ^[AB]
• Manufacturer: LUPIN LTD
  Approval date: December 18, 2012
  Strength(s): 3MG;0.03MG ^[AB]
• Manufacturer: MYLAN LABS LTD
  Approval date: May 4, 2015
  Strength(s): 3MG;0.03MG ^[AB]
• Manufacturer: NAARI PTE LTD
  Approval date: November 22, 2016
  Strength(s): 3MG;0.03MG ^[AB]

SYEDA (drospirenone; ethinyl estradiol tablet;oral-28)

• Manufacturer: XIROMED
  Approval date: March 28, 2011
  Strength(s): 3MG;0.03MG ^[AB]

YAELA (drospirenone; ethinyl estradiol tablet;oral-28)

• Manufacturer: NOVAST LABS
  Approval date: November 19, 2014
  Strength(s): 3MG;0.03MG ^[AB]

ZUMANDIMINE (drospirenone; ethinyl estradiol tablet;oral-28)

• Manufacturer: AUROBINDO PHARMA LTD
  Approval date: March 26, 2018
  Strength(s): 3MG;0.03MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Yasmin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

More about Yasmin (drospirenone / ethinyl estradiol)

• Check interactions
• Compare alternatives
• Pricing & coupons
• Reviews (599)
• Drug images
• Latest FDA alerts (5)
• Side effects
• Dosage information
• During pregnancy
• Support group
• Drug class: contraceptives
• En español

Patient resources

• Drug Information
• Yasmin 28

Other brands

Yaz, Ocella, Loryna, Syeda, … +7 more

Professional resources

• Prescribing Information

Related treatment guides

• Acne
• Birth Control
• Premenstrual Dysphoric Disorder

Glossary

Term	Definition
Drug Patent	A drug patent is assigned by the U. S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug Exclusivity	Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.
RLD	A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.
AB	Products meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading (e.g. identical active ingredients, dosage form, and routes of administration) and having the same strength (see Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (e.g. AB1, AB2, AB7). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Yasmin Alternatives Compared – Drugs.com

Yasmin Alternatives Compared – Drugs.com
Skip to main content

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.

Prescription only Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Yasmin may also be used for purposes not listed in this medication guide.	</p> <p> Mirena may also be used for purposes not listed in this comparison guide. </p> ”> Prescription only Prescribed for Abnormal Uterine Bleeding, Birth Control. Mirena may also be used for purposes not listed in this medication guide.	</p> ”> Prescription only Prescribed for Birth Control. Nexplanon may also be used for purposes not listed in this medication guide.	Related suggestions Birth Control (Contraception) Lo Loestrin Fe NuvaRing Sprintec Depo-Provera Yaz Norethindrone Popular comparisons Yasmin vs Apri Yasmin vs Blisovi Fe 1 / 20 Yasmin vs Aviane Yasmin vs Blisovi 24 Fe Yasmin vs Aurovela Fe 1 / 20 Yasmin vs Aurovela Fe 1. 5 / 30
More about Yasmin (drospirenone / ethinyl estradiol)	More about Mirena (levonorgestrel)	More about Nexplanon (etonogestrel)
Generic Status
Lower-cost generic is available	Lower-cost generic is available	No lower-cost generic available
Ratings & Reviews
Yasmin has an average rating of 5.1 out of 10 from a total of 599 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 43% reported a negative effect.	Mirena has an average rating of 6.0 out of 10 from a total of 2587 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 32% reported a negative effect.	Nexplanon has an average rating of 5.1 out of 10 from a total of 4840 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 42% reported a negative effect.
View all 599 reviews	View all 2587 reviews	View all 4840 reviews
Drug Class
Contraceptives	Contraceptives Progestins	Contraceptives Progestins
Side Effects
See also: Yasmin side effects in more detail.	See also: Mirena side effects in more detail.	Common side effects include: irregular menses weight gain See also: Nexplanon side effects in more detail.
Pricing and Coupons * Prices are without insurance
Quantity 84 each Dosage 3 mg-0.03 mg Per Unit* $4.96 Cost* $416.38 View all Yasmin prices and generic prices	Quantity 1 device Dosage 52 mg Per Unit* $1,169. 59 Cost* $1,169.59 View all Mirena prices and generic prices	Quantity 1 implant Dosage 68 mg Per Unit* $1,159.88 Cost* $1,159.88 View all Nexplanon prices
Get free Discount Card	Get free Discount Card	Get free Discount Card
Dosage Form(s) Available
Oral tablet	Intrauterine device	Subcutaneous implant
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value.
32.5 hours	45 hours	25 hours
CSA Schedule ** View glossary of terms
Is not subject to the Controlled Substances Act.	Is not subject to the Controlled Substances Act.	Is not subject to the Controlled Substances Act.
Pregnancy Category
See the full pregnancy warnings document.	See the full pregnancy warnings document.	See the full pregnancy warnings document.
Drug Interactions
A total of 536 drugs are known to interact with Yasmin: 69 major drug interactions (176 brand and generic names) 426 moderate drug interactions (1695 brand and generic names) 41 minor drug interactions (495 brand and generic names)	A total of 239 drugs are known to interact with Mirena: 36 major drug interactions (103 brand and generic names) 189 moderate drug interactions (592 brand and generic names) 14 minor drug interactions (67 brand and generic names)	A total of 226 drugs are known to interact with Nexplanon: 35 major drug interactions (101 brand and generic names) 182 moderate drug interactions (547 brand and generic names) 9 minor drug interactions (49 brand and generic names)
Alcohol/Food/Lifestyle Interactions
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.	Grapefruit juice may increase the blood levels of certain medications such as levonorgestrel. You… View more	Grapefruit juice may increase the blood levels of certain medications such as etonogestrel. You… View more
Disease Interactions
Smoking Hyperkalemia Abnormal vaginal bleeding Carcinomas (estrogenic) Hypercalcemia in breast cancer Hypertension Thromboembolism/cardiovascular Hepatic neoplasms Angioedema Gallbladder disease Hypercalcemia Hyperlipidemia Liver disease Melasma Depression Fluid retention Glucose intolerance Retinal thrombosis Thyroid function tests	Abnormal genital bleeding Hepatic neoplasms Intracranial HTN Thromboembolism Breast malignancy Liver disease Depression Fluid retention Glucose intolerance Retinal thrombosis Thyroid function tests Hyperlipidemia Weight gain	Abnormal genital bleeding Hepatic neoplasms Breast malignancy Liver disease Thromboembolism Depression Fluid retention Retinal thrombosis Gallbladder disease
First Approval Date
May 11, 2001	December 06, 2000	July 17, 2006
WADA Class View World Anti-Doping Agency classifications.
N/A	N/A	N/A
More Information
Side effects Pregnancy warnings Dosage information Drug images Drug interactions Support group Pricing and coupons En Español	Side effects Pregnancy warnings Dosage information Drug interactions Support group Pricing and coupons En Español	Side effects Pregnancy warnings Breastfeeding warnings Dosage information Drug images Drug interactions Support group Pricing and coupons En Español
Patient resources
Overview	Overview	Overview
Professional Resources
Prescribing information	Prescribing information	Prescribing information

** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Results of pharmacoeconomic studies on drugs Jess and Yarin

All articles

08/18/2021

Premenstrual disorders are widespread among women all over the world. These violations significantly reduce the quality of life, social activity, as well as the efficiency of women’s work. The most severe are premenstrual syndrome (PMS) and premenstrual dysphoric disorders (PMDD).

Therapy of these disorders is extremely important. The results of the study [1] indicate that patients with moderate to severe manifestations of PMS/PMDD during one menstrual cycle cannot perform 8 hours more (1 working day) than patients with mild manifestations of PMS/PMDD or without PMS/PMDD. Also, according to the complication severity questionnaire, in the group of patients with moderate and severe manifestations of PMS/PMDD, the state of reduced working capacity and social activity (observation – 2 months) lasted 4. 5 days longer than in the group of patients without PMS/PMDD or with mild degree (5.6 days versus 1.1 days). The findings of this study are supported by data from the IMPACT and Extension studies.

Comparative treatment efficacy studies PMS / PMDD between Yasmin 9 0014 and competitors

Another indication for prescribing drospirenone-containing drugs is contraception. According to the results of modern research, all oral contraceptives have comparable efficacy and safety profiles. Therefore, the standard design of a pharmacoeconomic study in this case will not be informative. To take into account the overall complex of positive effects of drospirenone-containing contraceptives, a joint analysis was carried out [3]. Parameters assessed included dosage tolerance, weight gain, effects on skin and hair, effects on premenstrual syndromes, menstrual bleeding, and drug cost. An overall utility index of the studied alternatives was derived (Yasmin, EE 30 + DSG 150, EE 20 + DSG 150). As a result of the survey, it was found that Yasmin has an advantage over comparators in all additional parameters (in terms of tolerability, as well as indicators of weight gain, effects on the skin and hair, premenstrual syndromes and menstrual bleeding). The analysis showed that in order to receive an additional unit of benefit when using Yasmin, it is necessary to spend an additional 19€2 compared to EE 30 + DSG 150 and €104.82 compared to EE 20 + DSG 150. The study was conducted in Portugal.

To assess the budgetary impact of Yasmin in terms of unwanted pregnancies avoided, a pharmacoeconomic study was conducted in Scotland. In a simulation with a time horizon of 6 years, Yasmin prevented an additional 995 unwanted pregnancies compared to other non-oral contraceptive methods. The cost of preventing one additional unwanted pregnancy was £72.

The results of pharmacoeconomic studies show that the use of Yasmin provides both a wide range of contraceptive and non-contraceptive positive effects and is economically justified.

Literature

1. Heinemann L.A.J. et al. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. Women’s Health Issues 20 (2010), pp 58-65

Related links:

Description of the drug Yarina

YASMIN 1608 St. grey, 230 cm

On request

Delivery will be made within one week from the date of order

Order

Calculate cost per m ²

Height

Width 9000 3

Get a quote

*Exact price
calculated by manager

You may also be interested

SHIKATAN Tea ceremony 2868 light brown 180cm

On request

Colour:
Brown / Caramel

Structure:
fine textured / natural look

Country of origin:
CHINA

SILK 4240 peach, 200cm

On request

Colour:
Peach

Structure:
jacquard / glitter

Country of origin:
TAIWAN (CHINA)

Roller blind PLAIN 1852 grey, 200 cm

On request

Colour:
Gray

Structure:
smooth

Country of origin:
CHINA

Roller blind ALFA 0225 white 200cm

On request

Colour:
White

Structure:
smooth

Country of origin:
CHINA

SILK II 2261 St. beige, 200 cm

On request

Colour:
Beige

Structure:
jacquard / glitter

Country of origin:
TAIWAN (CHINA)

SILK II 1608 St. grey, 200 cm

On request

Colour:
Gray

Structure:
jacquard / glitter

Country of origin:
TAIWAN (CHINA)

SILK II 0225 white, 200 cm

On request

Colour:
White

Structure:
jacquard / glitter

Country of origin:
TAIWAN (CHINA)

Roller blind RUAN 1852 grey, 220 cm

On request

Colour:
Gray

Structure:
jacquard

Country of origin:
Turkey

Roller blind RUAN 0225 white, 220 cm

On request

Colour:
White

Structure:
jacquard

Country of origin:
Türkiye

Roller blinds RUAN 1608 St.